Microglia are activated in response to injury, infection, and toxic pro-inflammatory molecules that threaten neuronal survival. Long-term microglial activation plays a crucial role in the progression of neurodegenerative diseases, and negative regulators of this process have been recognized as potential therapeutic options for various neurological disorders. In this study, we evaluated the effects of Cyrtomium falcatum (L.f.) Presl (CFL) extracts on lipopolysaccharide (LPS)-induced activation of BV2 microglial cells. CFL extracts significantly reduced excessive nitric oxide production in LPS-stimulated BV2 cells and decreased the expression of inducible nitric oxide synthase, cyclooxygenase-2, and pro-inflammatory cytokines, including interleukin-1β (IL-1β), interleukin-6 (IL-6), and tumor necrosis factor-α (TNF-α). Pretreatment with CFL extracts markedly suppressed the phosphorylation of mitogen-activated protein kinases (p38, JNK, and ERK1/2) and nuclear factor kappa B and modulated the antioxidant transcription factor, nuclear factor erythroid 2–related factor 2. In conclusion, these results indicate that CFL extracts exert neuroprotective effects by inhibiting pro-inflammatory signaling pathways and modulating antioxidant defense mechanisms, suggesting their potential as therapeutic candidates for neuroinflammatory disorders.
SubhramanyamCS, WangC, HuQ, et al.Microglia-mediated neuroinflammation in neurodegenerative diseases. Semin Cell Dev Biol, 2019; 94:112–120; doi: 10.1016/j.semcdb.2019.05.004
2.
LeeJ-W, ChunW, LeeHJ, et al.The role of microglia in the development of neurodegenerative diseases. Biomedicines, 2021; 9(10):1449; doi: 10.3390/biomedicines9101449
3.
AndrewPM, LeinPJ. Neuroinflammation as a therapeutic target for mitigating the long-term consequences of acute organophosphate intoxication. Front Pharmacol, 2021; 12:674325; doi: 10.3389/fphar.2021.674325
LeeJM, JohnsonJA. An important role of Nrf2-ARE pathway in the cellular defense mechanism. J Biochem Mol Biol, 2004; 37(2):139–143; doi: 10.5483/BMBRep.2004.37.2.139
14.
BellezzaI, GiambancoI, MinelliA, et al.Nrf2-Keap1 signaling in oxidative and reductive stress. Biochim Biophys Acta Mol Cell Res, 2018; 1865(5):721–733; doi: 10.1016/j.bbamcr.2018.02.010
15.
CuadradoA, RojoAI, WellsG, et al.Therapeutic targeting of the NRF2 and KEAP1 partnership in chronic diseases. Nat Rev Drug Discov, 2019; 18(4):295–317; doi: 10.1038/s41573-018-0008-x
16.
RabbaniN, ThornalleyPJ. Glyoxalase inhibition in aging and neurodegeneration. Biochem Soc Trans, 2021; 49(3):1381–1394.
17.
ImaiR, TsudaY, EbiharaA, et al.Mating system evolution and genetic structure of diploid sexual populations of Cyrtomium falcatum in Japan. Sci Rep, 2021; 11(1):3124; doi: 10.1038/s41598-021-82731-1
18.
RamanG, ChoiKS, ParkS. Phylogenetic relationships of the fern Cyrtomium falcatum (Dryopteridaceae) from Dokdo Island based on chloroplast genome sequencing. Genes (Basel), 2016; 7(12):115; doi: 10.3390/genes7120115
19.
ThakurS, DhapolaR, SarmaP, et al.Neuroinflammation in Alzheimer’s disease: Current progress in molecular signaling and therapeutics. Inflammation, 2023; 46(1):1–17; doi: 10.1007/s10753-022-01721-1
20.
MorrisSM, BilliarTR. New insights into the regulation of inducible nitric oxide synthesis. Am J Physiol, 1994; 266(6 Pt 1):E829–E839; doi: 10.1152/ajpendo.1994.266.6.E829
21.
ErdoganA, OzhanY, SipahiH, et al.iNOS/PGE(2) inhibitors as a novel template for analgesic/anti-inflammatory activity: Design, synthesis, in vitro biological activity and docking studies. Arch Pharm (Weinheim), 2024; 357(12):e2400238; doi: 10.1002/ardp.202400238
22.
AnJ, ChenB, KangX, et al.Neuroprotective effects of natural compounds on LPS-induced inflammatory responses in microglia. Am J Transl Res, 2020; 12(6):2353–2378.
23.
VasudevanSD, ThaggikuppePK, ChakkittukandiyilA, et al.Orientin modulates Nrf2-ARE, PI3K/Akt, JNK-ERK1/2, and TLR4/NF-jB pathways to produce neuroprotective benefits in Parkinson’s disease. Neurochem Res, 2024; 49:1577–1587; doi: 10.1007/s11064-024-04099-8
24.
Abou BakerDH. An ethnopharmacological review on the therapeutical properties of flavonoids and their mechanisms of actions: A comprehensive review based on up to date knowledge. Toxicol Rep, 2022; 9:445–469; doi: 10.1016/j.toxrep.2022.03.011
KhanH, TundisR, UllahH, et al.Flavonoids targeting NRF2 in neurodegenerative disorders. Food Chem Toxicol, 2020; 146:111817; doi: 10.1016/j.fct.2020.111817
27.
DaviesDA, AdlimoghaddamA, AlbensiBC. Role of Nrf2 in synaptic plasticity and memory in Alzheimer’s disease. Cells, 2021; 10(8):1884; doi: 10.3390/cells10081884
28.
HuS, MaitiP, MaQ, et al.Clinical development of curcumin in neurodegenerative disease. Expert Rev Neurother, 2015; 15(6):629–637; doi: 10.1586/14737175.2015.1044981
29.
MandelS, WeinrebO, AmitT, et al.Cell signaling pathways in the neuroprotective actions of the green tea polyphenol (-)-epigallocatechin-3-gallate: Implications for neurodegenerative diseases. J Neurochem, 2004; 88(6):1555–1569; doi: 10.1046/j.1471-4159.2003.02291.x
30.
XuX-J, PanT, FanH-J, et al.Neuroprotective effect of hyperoside in MPP+/MPTP-induced dopaminergic neurodegeneration. Metab Brain Dis, 2023; 38(3):1035–1050; doi: 10.1007/s11011-022-01153-8
31.
LiS, LiangT, ZhangY, et al.Vitexin alleviates high-fat diet induced brain oxidative stress and inflammation via anti-oxidant, anti-inflammatory and gut microbiota modulating properties. Free Radic Biol Med, 2021; 171:332–344; doi: 10.1016/j.freeradbiomed.2021.05.028
32.
RiazA, RasulA, HussainG, et al.Astragalin: A bioactive phytochemical with potential therapeutic activities. Adv Pharmacol Sci, 2018; 2018:9794625; doi: 10.1155/2018/9794625
